share_log

Clover Health Investments Analyst Ratings

Benzinga ·  Aug 11, 2023 21:24
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/11/2023 13.64% Citigroup $1 → $1.5 Maintains Neutral
03/06/2023 127.27% Canaccord Genuity $4 → $3 Maintains Buy
03/06/2023 -5.3% Credit Suisse $2.5 → $1.25 Maintains Underperform
11/16/2022 36.36% Citigroup $3.5 → $1.8 Maintains Neutral
11/08/2022 13.64% SVB Leerink $3 → $1.5 Maintains Market Perform
08/09/2022 165.15% Citigroup $3 → $3.5 Maintains Neutral
08/09/2022 127.27% Credit Suisse $3.5 → $3 Maintains Underperform
05/10/2022 127.27% SVB Leerink $2.5 → $3 Maintains Market Perform
02/25/2022 89.39% SVB Leerink $3 → $2.5 Maintains Market Perform
02/02/2022 354.55% Canaccord Genuity → $6 Initiates Coverage On → Buy
02/02/2022 127.27% Cowen & Co. $7 → $3 Upgrades Underperform → Market Perform
01/19/2022 127.27% SVB Leerink → $3 Initiates Coverage On → Market Perform
01/07/2022 165.15% Credit Suisse $9 → $3.5 Downgrades Neutral → Underperform
11/15/2021 581.82% Credit Suisse $8 → $9 Maintains Neutral
09/10/2021 430.3% Cowen & Co. → $7 Initiates Coverage On → Underperform
07/12/2021 581.82% JP Morgan → $9 Downgrades Neutral → Underweight
06/10/2021 657.58% B of A Securities → $10 Downgrades Neutral → Underperform
05/19/2021 581.82% Credit Suisse $10 → $9 Maintains Neutral
05/17/2021 581.82% B of A Securities $15 → $9 Downgrades Buy → Neutral
03/09/2021 657.58% Credit Suisse → $10 Initiates Coverage On → Neutral
02/02/2021 1339.39% Citigroup → $19 Initiates Coverage On → Buy
02/01/2021 1036.36% JP Morgan → $15 Initiates Coverage On → Neutral

What is the target price for Clover Health Investments (CLOV)?

The latest price target for Clover Health Investments (NASDAQ: CLOV) was reported by Citigroup on August 11, 2023. The analyst firm set a price target for $1.50 expecting CLOV to rise to within 12 months (a possible 13.64% upside). 5 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Clover Health Investments (CLOV)?

The latest analyst rating for Clover Health Investments (NASDAQ: CLOV) was provided by Citigroup, and Clover Health Investments maintained their neutral rating.

When is the next analyst rating going to be posted or updated for Clover Health Investments (CLOV)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Clover Health Investments, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Clover Health Investments was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.

Is the Analyst Rating Clover Health Investments (CLOV) correct?

While ratings are subjective and will change, the latest Clover Health Investments (CLOV) rating was a maintained with a price target of $1.00 to $1.50. The current price Clover Health Investments (CLOV) is trading at is $1.32, which is within the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment